Lj. Abraham et Km. Kroeger, Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease, J LEUK BIOL, 66(4), 1999, pp. 562-566
A biallelic G (TNF1 allele) to A (TNF2 allele) polymorphism 308 nucleotides
upstream from the transcription initiation site in the tumor necrosis fact
or (TNF) promoter is associated with elevated TNF levels and disease suscep
tibilities observed in human subjects. The TNF2 allele is strongly associat
ed with the high-TNF-producing autoimmune MHC haplotype HLA-A1, B8, DR3, wi
th elevated serum TNF levels and a more severe outcome in infectious diseas
es, such as cerebral malaria, A number of groups have set out to determine
whether the -308 polymorphism could affect transcription factor binding and
hence influence TNF transcription and expression levels. Although some stu
dies have failed to show any functional difference between the two allelic
forms, others have shown that the -308 polymorphism effected transcription
factor binding to the region encompassing -308, with the region in the TNF2
allele showing altered binding characteristics. The -308 polymorphism also
has been found by some groups to be functionally significant in reporter g
ene assays in Raji B cells, Jurkat T cells, and U937 pre-monocytic cells, U
p to fivefold differences can be measured between TNF1 and TNF2 allelic con
structs when the TNF 3'UTR is present, indicating a role in the expression
of the polymorphism, Although controversial, the majority of the data suppo
rt a direct role for the TNF2 -308 allele in the elevated TNF levels observ
ed in TNF2 homozygotes nd HLA-A1, B8, DR3 individuals, Elevated TNF levels
due to the -308 polymorphism may alter tbe immune response such that it con
fers susceptibility to certain autoimmune and infectious diseases.